Belgium· BE-AMP-SAM429843-00
Cleviprex 0.5 mg/ml
A clevidipine product containing clevidipine butyrate, registered in Belgium by Chiesi. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Clevidipine is registered in 8 of 19 countries.
Countries holding a registration under ATC C08CA16 (clevidipine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Clevidipine · ATC C08CA16
8 / 19 countries
- Belgiumprice
- Canada
- Franceprice
- Germany
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Clevidipine Butyrate
- Manufacturer
- Chiesi
- Country
- Belgium (BE)
- ATC code
- C08CA16
- ATC class
- Clevidipine
- Defined daily dose
- 0.12 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3413325
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for clevidipine.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clevidipine · interactions on record
92 records
- 5 severe
- 85 moderate
- 1 minor
Most severe, free to view
- DolasetronA04AA04severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- SiponimodL04AA42severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clevidipine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCLEVIPREX 0,5MG/ML EMULSION INYECTABLEChiesi España S.A.U.
- SwedenCleviprex 0,5 mg/ml Injektionsvätska, emulsionChiesi Farmaceutici S.p.A.
- United StatesCleviprexChiesi USA, Inc.
- CanadaCLEVIPREXCHIESI FARMACEUTICI S.P.A.
- SwitzerlandCleviprex, emulsion pour perfusionChiesi SA
- GermanyCleviprexChiesi Gmbh
- United KingdomCleviprex 25mg/50ml emulsion for infusion vialsChiesi Ltd
- NetherlandsCleviprex 0,5 mg/ml, emulsie voor injectieChiesi Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Cleviprex
- Germany · Cleviprex
- Spain · Cleviprex
- France · Cleviprex
- Italy · Cleviprex
- Luxembourg · Cleviprex
- Netherlands · Cleviprex
- Sweden · Cleviprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dab8c67d-00e5-4f7d-8f3e-81e25c9acb0f GET /v1/drugs/dab8c67d-00e5-4f7d-8f3e-81e25c9acb0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsion for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Cleviprex 0.5 mg/ml",
"name_fr": "Cleviprex 0.5 mg/ml",
"name_nl": "Cleviprex 0.5 mg/ml",
"amp_code": "SAM429843-00",
"strengths": [
"25.0000",
"1.1300",
"10.0000"
],
"pack_count": 1,
"substances": [
"Clevidipine Butyrate",
"Glycerol",
"Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil - Refined",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Clevidipine",
"authorisation_numbers": [
"BE429843"
]
}See everything about clevidipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.